108 related articles for article (PubMed ID: 11928630)
21. The effects of ursodeoxycholic acid on serum and biliary noncholesterol sterols in patients with gallstones.
Miettinen TE; Tarpila S; Gylling H
Hepatology; 1997 Mar; 25(3):514-8. PubMed ID: 9049189
[TBL] [Abstract][Full Text] [Related]
22. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
[TBL] [Abstract][Full Text] [Related]
23. Effect of ursodeoxycholic acid administration after liver transplantation on serum liver tests and biliary complications: a randomized clinical trial.
Wang SY; Tang HM; Chen GQ; Xu JM; Zhong L; Wang ZW; Deng GL; Xing TH; Lu LG; Peng ZH
Digestion; 2012; 86(3):208-17. PubMed ID: 22948036
[TBL] [Abstract][Full Text] [Related]
24. Bile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion.
Quintero P; Pizarro M; Solís N; Arab JP; Padilla O; Riquelme A; Arrese M
J Physiol Biochem; 2014 Sep; 70(3):667-74. PubMed ID: 24816727
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes.
Qiao L; Yacoub A; Studer E; Gupta S; Pei XY; Grant S; Hylemon PB; Dent P
Hepatology; 2002 Apr; 35(4):779-89. PubMed ID: 11915023
[TBL] [Abstract][Full Text] [Related]
26. Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers.
Mazzella G; Rizzo N; Azzaroli F; Simoni P; Bovicelli L; Miracolo A; Simonazzi G; Colecchia A; Nigro G; Mwangemi C; Festi D; Roda E
Hepatology; 2001 Mar; 33(3):504-8. PubMed ID: 11230728
[TBL] [Abstract][Full Text] [Related]
27. Effects of selective zonal injury on bile acid-induced bile flow in the isolated rat liver.
Monte MJ; Badia MD; Palomero F; el-Mir MY; Alonso JR; Marin JJ
Am J Physiol; 1993 Jun; 264(6 Pt 1):G1103-11. PubMed ID: 8333538
[TBL] [Abstract][Full Text] [Related]
28. Modulation of colonic xenobiotic metabolizing enzymes by feeding bile acids: comparative effects of cholic, deoxycholic, lithocholic and ursodeoxycholic acids.
Baijal PK; Fitzpatrick DW; Bird RP
Food Chem Toxicol; 1998 Jul; 36(7):601-7. PubMed ID: 9687967
[TBL] [Abstract][Full Text] [Related]
29. The effect of drugs on bile flow and composition. An overview.
Okolicsanyi L; Lirussi F; Strazzabosco M; Jemmolo RM; Orlando R; Nassuato G; Muraca M; Crepaldi G
Drugs; 1986 May; 31(5):430-48. PubMed ID: 2872047
[TBL] [Abstract][Full Text] [Related]
30. Combination of ursodeoxycholic acid and glucocorticoids upregulates the AE2 alternate promoter in human liver cells.
Arenas F; Hervias I; Uriz M; Joplin R; Prieto J; Medina JF
J Clin Invest; 2008 Feb; 118(2):695-709. PubMed ID: 18188457
[TBL] [Abstract][Full Text] [Related]
31. Effects of ursodeoxycholic acid on synthesis of cholesterol and bile acids in healthy subjects.
Sauter GH; Thiessen K; Parhofer KG; Jüngst C; Fischer S; Jüngst D
Digestion; 2004; 70(2):79-83. PubMed ID: 15375335
[TBL] [Abstract][Full Text] [Related]
32. Effect of intraduodenal administration of ursodeoxycholic acid on interdigestive interaction between gallbladder motility, pancreatic secretion and endocrine activity.
Neubrand MW; Dominguez-Munoz JE; Reichel C; Kampmann S; Eschmann K; von Falkenhausen M; Bregulla M; Malfertheiner P; Sauerbruch T
Digestion; 2004; 69(3):149-57. PubMed ID: 15114045
[TBL] [Abstract][Full Text] [Related]
33. Changes in biliary lipid secretion and cholic acid kinetics induced by diet, diet plus simvastatin and diet plus ursodeoxycholic acid in obese subjects.
Mazzella G; Cipolla A; Villanova N; Polimeni C; Sipahi A; Parini P; Fusaroli P; Festi D; Roda E
Ital J Gastroenterol; 1995; 27(8):441-5. PubMed ID: 8775472
[TBL] [Abstract][Full Text] [Related]
34. Effect of administration of ursodeoxycholic acid at bedtime on cholesterol saturation of hepatic bile in Japanese patients with gallstone.
Inoi J; Shimizu I; Tsuji Y; Muguruma N; Shibata H; Ito S
J Med Invest; 1998 Aug; 45(1-4):115-22. PubMed ID: 9864972
[TBL] [Abstract][Full Text] [Related]
35. Biliary secretion: future perspectives.
Hofmann AF
Digestion; 1997; 58 Suppl 1():24-8. PubMed ID: 9225085
[No Abstract] [Full Text] [Related]
36. Ursodeoxycholic Acid (UDCA) Promotes Lactate Metabolism in Mouse Hepatocytes through Cholic Acid (CA) - Farnesoid X Receptor (FXR) Pathway.
Wang L; He HW; Zhou X; Long Y
Curr Mol Med; 2020; 20(8):661-666. PubMed ID: 31971110
[TBL] [Abstract][Full Text] [Related]
37. [Effect of dehydrocholic acid and oxaphenamide on the bile secretory function of the liver in adrenalectomized animals].
Lesiuk II
Farmakol Toksikol; 1968; 31(2):200-2. PubMed ID: 5674676
[No Abstract] [Full Text] [Related]
38. Mechanism of hepatoprotective action of bile salts in liver disease.
Stiehl A; Benz C; Sauer P
Gastroenterol Clin North Am; 1999 Mar; 28(1):195-209, viii. PubMed ID: 10198785
[TBL] [Abstract][Full Text] [Related]
39. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
Stiehl A; Rudolph G; Sauer P; Theilmann L
J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
[TBL] [Abstract][Full Text] [Related]
40. Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-alpha/beta in the adaptive response to bile acids.
Zollner G; Wagner M; Moustafa T; Fickert P; Silbert D; Gumhold J; Fuchsbichler A; Halilbasic E; Denk H; Marschall HU; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G923-32. PubMed ID: 16357057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
